Ascentage Pharma Group International (NASDAQ:AAPG) Trading Up 3.5% – Here’s What Happened

Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG)’s share price rose 3.5% during mid-day trading on Wednesday . The stock traded as high as $40.23 and last traded at $40.23. Approximately 6,795 shares were traded during trading, a decline of 18% from the average daily volume of 8,278 shares. The stock had previously closed at $38.88.

Ascentage Pharma Group International Price Performance

The company has a current ratio of 1.54, a quick ratio of 1.53 and a debt-to-equity ratio of 1.31. The firm’s fifty day simple moving average is $40.85 and its 200-day simple moving average is $33.02.

Institutional Trading of Ascentage Pharma Group International

Large investors have recently modified their holdings of the stock. Chevy Chase Trust Holdings LLC acquired a new stake in Ascentage Pharma Group International in the 2nd quarter valued at $227,000. Hsbc Holdings PLC purchased a new position in Ascentage Pharma Group International during the 2nd quarter valued at about $391,000. Tema Etfs LLC purchased a new position in Ascentage Pharma Group International during the 2nd quarter valued at about $610,000. Finally, Monashee Investment Management LLC purchased a new position in Ascentage Pharma Group International during the 1st quarter valued at about $3,511,000.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.